Lest this week’s news about FDA cautioning against the use of plastic syringes made in China raise concerns of a possible shortage, BD announced today that it is increasing its US production of ...

After the U.S. Food and Drug Administration announced an investigation into reports of leaks, breakages and other quality issues with China-made plastic syringes, New Jersey-based medical technology ...

The FDA last week re-upped its recommendations that healthcare providers avoid using plastic syringes made in China wherever possible, while it continues to investigate growing quality concerns. In ...

Months after the FDA told healthcare facilities to avoid plastic syringes made in China because of leaking issues, four companies have recently recalled products. Since November 2023, the FDA has ...

The U.S. Food and Drug Administration's Center for Devices and Radiological Health has warned that Chinese-made plastic syringes that are distributed in the U.S. have "more widespread" quality control ...

BD (NYSE:BDX) announced Thursday that the company has increased its domestic manufacturing of syringes after the FDA warned about quality issues linked to plastic syringes made in China. Since the FDA ...

The U.S. Food and Drug Administration has issued a safety notice to consumers, health care providers and facilities that it is evaluating plastic syringes made in China for potential device failures.

FDA recently announced an update to its safety communication recommending that US suppliers immediately transition away from using plastic syringes manufactured by specific China-based companies. In ...

Nearly six months after the FDA told healthcare workers to avoid plastic syringes made in China, the agency has placed import alerts on three China-based medical supply manufacturers. In late November ...

The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...